Citadel Advisors’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4787 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4625 |
|
|
2017
Q3 | – | Sell |
-20,920
| Closed | -$61K | – | 4514 |
|
|
2017
Q2 | $61K | Buy |
+20,920
| New | +$61K | ﹤0.01% | 3373 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 4605 |
|
|
2016
Q3 | – | Sell |
-81,256
| Closed | -$349K | – | 4553 |
|
|
2016
Q2 | $349K | Buy |
81,256
+79,141
| +3,742% | +$340K | ﹤0.01% | 2457 |
|
|
2016
Q1 | $12K | Buy |
2,115
+964
| +84% | +$5.47K | ﹤0.01% | 3244 |
|
|
2015
Q4 | $20K | Sell |
1,151
-15,707
| -93% | -$273K | ﹤0.01% | 3645 |
|
|
2015
Q3 | $356K | Buy |
16,858
+6,671
| +65% | +$141K | ﹤0.01% | 2828 |
|
|
2015
Q2 | $504K | Buy |
10,187
+5,943
| +140% | +$294K | ﹤0.01% | 2545 |
|
|
2015
Q1 | $332K | Sell |
4,244
-16,124
| -79% | -$1.26M | ﹤0.01% | 2877 |
|
|
2014
Q4 | $1.24M | Buy |
20,368
+13,453
| +195% | +$816K | ﹤0.01% | 1979 |
|
|
2014
Q3 | $295K | Buy |
6,915
+1,621
| +31% | +$69.2K | ﹤0.01% | 2717 |
|
|
2014
Q2 | $327K | Buy |
5,294
+620
| +13% | +$38.3K | ﹤0.01% | 2551 |
|
|
2014
Q1 | $304K | Sell |
4,674
-2,264
| -33% | -$147K | ﹤0.01% | 2611 |
|
|
2013
Q4 | $391K | Sell |
6,938
-127,598
| -95% | -$7.19M | ﹤0.01% | 2162 |
|
|
2013
Q3 | $8.26M | Buy |
134,536
+32,956
| +32% | +$2.02M | 0.01% | 782 |
|
|
2013
Q2 | $5.94M | Buy |
+101,580
| New | +$5.94M | 0.01% | 916 |
|